Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre

Citation
Jf. Desassis et al., Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre, NEPH DIAL T, 14(11), 1999, pp. 2692-2697
Citations number
36
Categorie Soggetti
Urology & Nephrology
Journal title
NEPHROLOGY DIALYSIS TRANSPLANTATION
ISSN journal
09310509 → ACNP
Volume
14
Issue
11
Year of publication
1999
Pages
2692 - 2697
Database
ISI
SICI code
0931-0509(199911)14:11<2692:POPAPH>2.0.ZU;2-1
Abstract
Background. Previous studies, detecting GB virus-C (GBV-C) or hepatitis G v irus (HGV) RNA by using reverse transcriptase polymerase chain reaction (RT -PCR), have shown that haemodialysis (HD) patients had a high risk of being infected and viraemic with this virus. A past GBV-C/HGV contact can now be detected by testing for antibodies directed against the GBV-C/HGV envelope protein E2 (anti-E2). Methods. In order to evaluate GBV-C/HGV contact, 120 patients undergoing ch ronic HD were tested for GBV-C:HGV RNA by RT-PCR and anti-E2 antibodies by ELISA. GBV-C/HGV viraemic patients were followed prospectively for 18 month s, and retrospectively when sera were stored. The total follow-up was betwe en 18 and 78 months. Results. GBV-C/HGV RNA was detected in 17 patients( 14%), and 18 patients(1 5%) had a significant level of anti-E2 antibodies. No positive anti-E2 spec imens were also positive for GBV-C/HGV RNA and vice versa. A total of 35 pa tients (29%) were contaminated with GBV-C/HGV. Sixteen of the 17 viraemic p atients had a persistent viraemia (follow-up 18-78 months) and one cleared the virus during the study period. A past or present GBV-C/HGV contact was statistically correlated with the duration of HD and hepatitis C virus(HCV) infection, but was independent of age, hepatitis B virus (HBV) infection, and alanine aminotransferase (ALT) level. Conclusions. Twenty-nine per cent of patients who underwent HD in our centr e have been infected by GBV-C/HGV, 49% were still viraemic and 51% have dev eloped anti-E2 antibodies, indicating a past contact with GBV-C/HGV. Our re sults demonstrate that the prevalence of GBV-C/HGV contact in HD was undere stimated when only RT-PCR was used. Therefore GBV-C/HGV contact is probably much more frequent in HD than previous studies would suggest and is at thi s time not correlated with hepatotoxicity. Anti-HCV antibodies blood screen ing since 1990 and recent changes in managing HD patients have probably red uced GBV-C/HGV contact in the same way.